MTNB — Matinas BioPharma Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- $44.87m
- $31.14m
- $1.10m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -17.4 | -22.4 | -23.3 | -21 | -22.9 |
Depreciation | |||||
Non-Cash Items | 3.44 | 5.3 | 6.25 | 6.27 | 5.6 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.492 | -0.509 | 1.53 | -4.79 | 1.67 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -14.1 | -17.4 | -15.2 | -19.2 | -15.3 |
Capital Expenditures | -0.406 | -0.006 | -0.26 | -0.892 | -0.218 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -5.61 | -40.7 | 17 | 5.77 | 13.5 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -6.01 | -40.7 | 16.8 | 4.88 | 13.2 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 29.9 | 48 | 6.96 | 0.079 | -0.007 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 9.75 | -9.99 | 8.51 | -14.2 | -2.04 |